Search results :

Repaglinide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: A10BX02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12
Hypoglycaemia 16% - 31% 7% x x x x x x x x x x x x
Headache 8% - 9% 8% - 11% x x x x x x x x x
Rhinitis 7% - 8% 3% - 8% x x x x x x x x x
Back pain 6% - 7% 4% - 7% x x x x x x x x x
Bronchitis 6% - 7% 1% - 7% x x x x x x x x x
Diarrhoea 4% - 6% 2% - 6% x x x x x x x x x x x
Dyspepsia 2% - 4% 2% - 4% x x x x x x x x x
Arthralgia 3% - 4% 3% - 6% x x x x x x x x x
Nausea 2% - 3% 2% - 5% x x x x x x x x x x x
Sinusitis 3% - 4% 2% - 6% x x x x x x x x x
Urinary tract infection 3% 1% - 3% x x x x x x x x x
Constipation 2% - 3% 2% - 3% x x x x x x x x x x x
Paraesthesia 1% - 2% 1% - 3% x x x x x x x x x
Vomiting 1% - 2% 1% - 3% x x x x x x x x x x x
Angina pectoris 1.8% x x x x x x x x x x
Chest pain 1% - 2% 1% - 3% x x x x x x x x x x
Hypersensitivity 1% 0% - 2% x x x x x x x x x x x
Tooth disorder 1% 0% - 2% x x x x x x x x x
Abdominal pain x x
Alopecia x x x x x x x x x x
Anaphylactic shock x x
Haemolytic anaemia x x x x x x x x x x
Arrhythmia x x x x x x x x x x
Cardiovascular disorder x x
Oedema x x x x x x x x x
Rash x x
Eye disorder x x
Gastrointestinal disorder x x
Cardiac disorder x x
Cardiac failure congestive x x x x x x x x x
Hepatitis x x x x x x
Hyperglycaemia x x x x x x
Hypertension x x x x x x x x x x
Hypoglycaemic coma x x
Immune system disorder x x
Ischaemia x x x x x x x x x x
Jaundice x x x x x x
Leukopenia x x x x x x x x x x
Myocardial infarction x x x x x x x x x x
Palpitations x x x x x x x x x x
Pancreatitis x x x x x x x x x x
Pruritus x x
Refraction disorder x x
Stevens-Johnson syndrome x x x x x x x x x x
Thrombocytopenia x x x x x x x x x x
Erythema x x
Urticaria x x
Vasculitis x x
Oedema peripheral x x x x x x x x x
Hepatic function abnormal x x x x x x x x x x x x
Myocardial ischaemia x x x x x x x
Malnutrition x
Unspecified disorder of skin and subcutaneous tissue x x
Hepatic enzyme increased x x x x x x x x x x
Hepatobiliary disease x x
Anaphylactoid reaction x x x x x x x x x x
Electrocardiogram abnormal x x x x x x x x x x
Visual disturbance x x
Hypoglycaemic unconsciousness x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

repaglinide / repaglinide

Side effects:25
Source:EMA

repaglinide / repaglinide

Side effects:26
Source:EMA

REPAGLINIDE

Side effects:25
Source:FDA Structured Product Label

repaglinide / Prandin

Side effects:33
Source:FDA

repaglinide / Prandin

Side effects:36
Source:FDA

repaglinide / Prandin

Side effects:36
Source:FDA

REPAGLINIDE / PRANDIN

Side effects:37
Source:FDA

REPAGLINIDE

Side effects:40
Source:FDA Structured Product Label

REPAGLINIDE

Side effects:40
Source:FDA Structured Product Label

REPAGLINIDE

Side effects:40
Source:FDA Structured Product Label

REPAGLINIDE

Side effects:40
Source:FDA Structured Product Label

REPAGLINIDE / PRANDIN

Side effects:40
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label